Literature DB >> 2551643

Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors.

J W Funder1, P T Pearce, R Smith, J Campbell.   

Abstract

In vitro, Type I receptors have high and equivalent affinity for aldosterone, corticosterone and cortisol: in vivo, physiological mineralocorticoid target tissues (kidney, colon, parotid) are highly aldosterone-selective, in contrast with hippocampus and heart. In the present study we show that the mesenteric vascular arcade is similarly highly aldosterone-selective in vivo, and in vitro shows considerable levels of 11 beta OH steroid dehydrogenase activity, previously postulated as the mechanism whereby glucocorticoids are excluded from physiological mineralocorticoid receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2551643     DOI: 10.1210/endo-125-4-2224

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  23 in total

Review 1.  Aldosterone and vascular damage.

Authors:  D Duprez; M De Buyzere; E R Rietzschel; D L Clement
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

Review 2.  Aldosterone antagonists in the treatment of hypertension and target organ damage.

Authors:  S Rajagopalan; B Pitt
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 3.  Aldosterone breakthrough during RAS blockade: a role for endothelins and their antagonists?

Authors:  Gian Paolo Rossi
Journal:  Curr Hypertens Rep       Date:  2006-06       Impact factor: 5.369

Review 4.  Aldosterone receptor blockade in the management of heart failure.

Authors:  Emiliano A Palmieri; Bernadette Biondi; Serafino Fazio
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 5.  Aldosterone: effects on the kidney and cardiovascular system.

Authors:  Marie Briet; Ernesto L Schiffrin
Journal:  Nat Rev Nephrol       Date:  2010-03-16       Impact factor: 28.314

Review 6.  Rationale for the use of aldosterone antagonists in congestive heart failure.

Authors:  Ricardo Rocha; Gordon H Williams
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Identification of ligand-selective peptide antagonists of the mineralocorticoid receptor using phage display.

Authors:  Jun Yang; Ching-yi Chang; Rachid Safi; James Morgan; Donald P McDonnell; Peter J Fuller; Colin D Clyne; Morag J Young
Journal:  Mol Endocrinol       Date:  2010-11-24

8.  Aortic cell apoptosis in rat primary aldosteronism model.

Authors:  Yongji Yan; Jinzhi Ouyang; Chao Wang; Zhun Wu; Xin Ma; Hongzhao Li; Hua Xu; Zheng Hu; Jun Li; Baojun Wang; Taoping Shi; Daojing Gong; Dong Ni; Xu Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-06-17

Review 9.  Mineralocorticoid receptors: distribution and activation.

Authors:  John W Funder
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

Review 10.  Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease.

Authors:  Amy McCurley; Adam McGraw; Dafina Pruthi; Iris Z Jaffe
Journal:  Pflugers Arch       Date:  2013-05-01       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.